AbVacc Email Formats

Biotechnology Research • Rockville, Maryland, United States • 1-10 Employees

AbVacc Email Formats

AbVacc uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@abvacc.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@abvacc.com	100%

Key Contact at AbVacc

Javad Aman

President & CSO

Company overview

Headquarters	Suite 310, 4 Research Ct, Rockville, Maryland 20850, US
Phone number	+13015150324
Website	abvacc.com
NAICS	541714
Keywords	Vaccines, Infectious Diseases, Virology, Antibody Therapeutics, Bacteriology, Rational Design
Founded	2023
Employees	1-10

About AbVacc

AbVacc, Inc. is a biotechnology company focused on the discovery of novel vaccines and therapeutics for emerging infectious diseases using structure-guided design. AbVacc’s pipeline includes promising product candidates for prevention and treatment of bacterial and viral infections. AbVacc’s bacterial program primary focus is on staphylococcal infections, by targeting a variety of virulence factors such as toxins and critical enzymes produced by S. aureus. AbVacc’s S. aureus vaccine (IBT-V02), developed for prevention of recurrent skin and soft tissues infection, is expected to enter the clinic in 2023. AbVacc has also developed a large collection potently neutralizing fully human and macaque-human chimeric antibodies against S. aureus virulence factors, currently under development for treatment of various S. aureus invasive diseases such as bacteremia and orthopedic infections. AbVacc’s antiviral pipeline includes unique Ebola and Marburg antibody therapeutics and vaccines for filoviruses and Nipah virus, and a strong discovery pipeline for emerging viruses. Further, AbVacc has developed a novel antibody engineering platform technology for targeting anti-toxin antibodies to the surface of bacteria, integrating toxin neutralization with effector functions. Located in Rockville, Maryland, AbVacc has a close working relationship with United States Government agencies including the National Institute of Allergy and Infectious Diseases (NIAID/NIH), National Cancer Institute (NCI), Department of Defense (DOD), United States Army Medical Research Institute of Infectious Diseases (USAMRIID), and many biotechnology and pharmaceutical companies and academic laboratories.